Tritonix.ai

News / Korea / yonhap_finance

Tech-Specialized Listing Scheme Reaches 300 Companies Milestone

Health Technology · Biotechnology · yonhap_finance · 2026-09-04

196170, 386380, 950200, 950220, 950250

The Korea Exchange's tech-specialized listing program has reached 300 companies 21 years after its inception, solidifying its role in KOSDAQ growth.

What Happened

Program Milestone: The Korea Exchange announced that the number of companies listed through the tech-specialized listing scheme has surpassed 300. Since its introduction in 2005, initially targeting the biotech sector, the program has become a vital gateway for innovative firms to enter the KOSDAQ market.

Growth Trajectory: The program reached 100 listings by 2020 and 200 by 2023, with Sky Labs marking the 300th milestone. The aggregate market capitalization of these companies at the time of listing has grown significantly over the past two decades, reflecting the program's success.

Valuation Performance: On average, the market capitalization of these tech-specialized firms has increased by 147% since their IPOs. Notable success stories, such as Alteogen, highlight the potential for significant value creation through this specialized listing pathway.

Future Strategy: The exchange continues to refine its oversight, including incentives for companies that comply with value-up disclosures. Moving forward, the KRX plans to strengthen its support for deep-tech firms in alignment with national industrial policies.

Read original

More in Health Technology

Curacle Announces 100 Billion Won Rights Offering for Operational Funding

Health Technology · yonhap_finance · 2026-09-04

Curacle has decided to raise approximately 100 billion KRW through a rights offering to secure working capital, issuing 7.1 million new shares.

115180

SkyLabs Shares Rise on KOSDAQ Debut After Early Volatility

Health Technology · yonhap_finance · 2026-09-04

Medical device manufacturer SkyLabs saw its shares climb above its IPO price on its first day of trading on the KOSDAQ market.

386380

Ennoconn Subsidiary AJ Bio Files for Phase III Clinical Trial of SBMA Drug

Health Technology · economic_daily · 2026-09-03

AJ Bio has submitted an IND application to the US FDA for its SBMA treatment, AJ201, aiming to leverage orphan drug status for global licensing deals.

7754

Latest in Korea

Kiwoom Securities Launches Naver Plus Store Integration with Up to 4% Point Rewards

Finance · yonhap_finance · 2026-09-04

Kiwoom Securities has introduced a new feature in its 'Youngwoongmun S#' app, allowing users to earn up to 4% in points on Naver Plus Store purchases.

039490

Curacle Announces 100 Billion Won Rights Offering for Operational Funding

Health Technology · yonhap_finance · 2026-09-04

Curacle has decided to raise approximately 100 billion KRW through a rights offering to secure working capital, issuing 7.1 million new shares.

115180

SoftBank Group Sets 4.75% Coupon for Record 1 Trillion Yen Retail Bond Issuance

Finance · yonhap_finance · 2026-09-04

SoftBank Group is issuing 1 trillion yen in retail bonds at a 4.75% coupon, marking the largest retail bond offering by a Japanese company to date.

US Senate Proposes Bill Allowing Private Firms to Conduct Military Cyber Operations

Technology Services · yonhap_finance · 2026-09-04

The US Senate is pushing to include a pilot program in the NDAA that would authorize private companies to execute military cyber operations under US Cyber Command.